Mitralign, Inc. Scrounges Up Another $8 Million

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mitralign adds another $8 million to its coffers a few months after closing enrollment on a clinical trial of its mitral valve repair device.

Mitralign added more than $8 million to its coffers in an equity funding round, after closing enrollment of a clinical trial for its namesake mitral valve repair device in April.

Help employers find you! Check out all the jobs and post your resume.

Back to news